Cargando…

Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study

BACKGROUND: Cerebrovascular reactivity (CVR) is inversely related to white matter hyperintensity severity, a marker of cerebral small vessel disease (SVD). Less is known about the relationship between CVR and other SVD imaging features or cognition. We aimed to investigate these cross-sectional rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Sleight, Emilie, Stringer, Michael S., Clancy, Una, Arteaga, Carmen, Jaime Garcia, Daniela, Hewins, Will, Jochems, Angela C.C., Hamilton, Olivia K.L., Manning, Cameron, Morgan, Alasdair G., Locherty, Rachel, Cheng, Yajun, Liu, Xiaodi, Zhang, Junfang, Hamilton, Iona, Jardine, Charlotte, Brown, Rosalind, Sakka, Eleni, Kampaite, Agniete, Wiseman, Stewart, Valdés-Hernández, Maria C., Chappell, Francesca M., Doubal, Fergus N., Marshall, Ian, Thrippleton, Michael J., Wardlaw, Joanna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589433/
https://www.ncbi.nlm.nih.gov/pubmed/37814956
http://dx.doi.org/10.1161/STROKEAHA.123.042656
_version_ 1785123790819164160
author Sleight, Emilie
Stringer, Michael S.
Clancy, Una
Arteaga, Carmen
Jaime Garcia, Daniela
Hewins, Will
Jochems, Angela C.C.
Hamilton, Olivia K.L.
Manning, Cameron
Morgan, Alasdair G.
Locherty, Rachel
Cheng, Yajun
Liu, Xiaodi
Zhang, Junfang
Hamilton, Iona
Jardine, Charlotte
Brown, Rosalind
Sakka, Eleni
Kampaite, Agniete
Wiseman, Stewart
Valdés-Hernández, Maria C.
Chappell, Francesca M.
Doubal, Fergus N.
Marshall, Ian
Thrippleton, Michael J.
Wardlaw, Joanna M.
author_facet Sleight, Emilie
Stringer, Michael S.
Clancy, Una
Arteaga, Carmen
Jaime Garcia, Daniela
Hewins, Will
Jochems, Angela C.C.
Hamilton, Olivia K.L.
Manning, Cameron
Morgan, Alasdair G.
Locherty, Rachel
Cheng, Yajun
Liu, Xiaodi
Zhang, Junfang
Hamilton, Iona
Jardine, Charlotte
Brown, Rosalind
Sakka, Eleni
Kampaite, Agniete
Wiseman, Stewart
Valdés-Hernández, Maria C.
Chappell, Francesca M.
Doubal, Fergus N.
Marshall, Ian
Thrippleton, Michael J.
Wardlaw, Joanna M.
author_sort Sleight, Emilie
collection PubMed
description BACKGROUND: Cerebrovascular reactivity (CVR) is inversely related to white matter hyperintensity severity, a marker of cerebral small vessel disease (SVD). Less is known about the relationship between CVR and other SVD imaging features or cognition. We aimed to investigate these cross-sectional relationships. METHODS: Between 2018 and 2021 in Edinburgh, we recruited patients presenting with lacunar or cortical ischemic stroke, whom we characterized for SVD features. We measured CVR in subcortical gray matter, normal-appearing white matter, and white matter hyperintensity using 3T magnetic resonance imaging. We assessed cognition using Montreal Cognitive Assessment. Statistical analyses included linear regression models with CVR as outcome, adjusted for age, sex, and vascular risk factors. We reported regression coefficients with 95% CIs. RESULTS: Of 208 patients, 182 had processable CVR data sets (median age, 68.2 years; 68% men). Although the strength of association depended on tissue type, lower CVR in normal-appearing tissues and white matter hyperintensity was associated with larger white matter hyperintensity volume (B(NAWM)=−0.0073 [95% CI, −0.0133 to −0.0014] %/mm Hg per 10-fold increase in percentage intracranial volume), more lacunes (B(NAWM)=−0.00129 [95% CI, −0.00215 to −0.00043] %/mm Hg per lacune), more microbleeds (B(NAWM)=−0.00083 [95% CI, −0.00130 to −0.00036] %/mm Hg per microbleed), higher deep atrophy score (B(NAWM)=−0.00218 [95% CI, −0.00417 to −0.00020] %/mm Hg per score point increase), higher perivascular space score (B(NAWM)=−0.0034 [95% CI, −0.0066 to −0.0002] %/mm Hg per score point increase in basal ganglia), and higher SVD score (B(NAWM)=−0.0048 [95% CI, −0.0075 to −0.0021] %/mm Hg per score point increase). Lower CVR in normal-appearing tissues was related to lower Montreal Cognitive Assessment without reaching convention statistical significance (B(NAWM)=0.00065 [95% CI, −0.00007 to 0.00137] %/mm Hg per score point increase). CONCLUSIONS: Lower CVR in patients with SVD was related to more severe SVD burden and worse cognition in this cross-sectional analysis. Longitudinal analysis will help determine whether lower CVR predicts worsening SVD severity or vice versa. REGISTRATION: URL: https://www.isrctn.com; Unique identifier: ISRCTN12113543.
format Online
Article
Text
id pubmed-10589433
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-105894332023-10-22 Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study Sleight, Emilie Stringer, Michael S. Clancy, Una Arteaga, Carmen Jaime Garcia, Daniela Hewins, Will Jochems, Angela C.C. Hamilton, Olivia K.L. Manning, Cameron Morgan, Alasdair G. Locherty, Rachel Cheng, Yajun Liu, Xiaodi Zhang, Junfang Hamilton, Iona Jardine, Charlotte Brown, Rosalind Sakka, Eleni Kampaite, Agniete Wiseman, Stewart Valdés-Hernández, Maria C. Chappell, Francesca M. Doubal, Fergus N. Marshall, Ian Thrippleton, Michael J. Wardlaw, Joanna M. Stroke Original Contributions BACKGROUND: Cerebrovascular reactivity (CVR) is inversely related to white matter hyperintensity severity, a marker of cerebral small vessel disease (SVD). Less is known about the relationship between CVR and other SVD imaging features or cognition. We aimed to investigate these cross-sectional relationships. METHODS: Between 2018 and 2021 in Edinburgh, we recruited patients presenting with lacunar or cortical ischemic stroke, whom we characterized for SVD features. We measured CVR in subcortical gray matter, normal-appearing white matter, and white matter hyperintensity using 3T magnetic resonance imaging. We assessed cognition using Montreal Cognitive Assessment. Statistical analyses included linear regression models with CVR as outcome, adjusted for age, sex, and vascular risk factors. We reported regression coefficients with 95% CIs. RESULTS: Of 208 patients, 182 had processable CVR data sets (median age, 68.2 years; 68% men). Although the strength of association depended on tissue type, lower CVR in normal-appearing tissues and white matter hyperintensity was associated with larger white matter hyperintensity volume (B(NAWM)=−0.0073 [95% CI, −0.0133 to −0.0014] %/mm Hg per 10-fold increase in percentage intracranial volume), more lacunes (B(NAWM)=−0.00129 [95% CI, −0.00215 to −0.00043] %/mm Hg per lacune), more microbleeds (B(NAWM)=−0.00083 [95% CI, −0.00130 to −0.00036] %/mm Hg per microbleed), higher deep atrophy score (B(NAWM)=−0.00218 [95% CI, −0.00417 to −0.00020] %/mm Hg per score point increase), higher perivascular space score (B(NAWM)=−0.0034 [95% CI, −0.0066 to −0.0002] %/mm Hg per score point increase in basal ganglia), and higher SVD score (B(NAWM)=−0.0048 [95% CI, −0.0075 to −0.0021] %/mm Hg per score point increase). Lower CVR in normal-appearing tissues was related to lower Montreal Cognitive Assessment without reaching convention statistical significance (B(NAWM)=0.00065 [95% CI, −0.00007 to 0.00137] %/mm Hg per score point increase). CONCLUSIONS: Lower CVR in patients with SVD was related to more severe SVD burden and worse cognition in this cross-sectional analysis. Longitudinal analysis will help determine whether lower CVR predicts worsening SVD severity or vice versa. REGISTRATION: URL: https://www.isrctn.com; Unique identifier: ISRCTN12113543. Lippincott Williams & Wilkins 2023-10-10 2023-11 /pmc/articles/PMC10589433/ /pubmed/37814956 http://dx.doi.org/10.1161/STROKEAHA.123.042656 Text en © 2023 The Authors. https://creativecommons.org/licenses/by/4.0/Stroke is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
spellingShingle Original Contributions
Sleight, Emilie
Stringer, Michael S.
Clancy, Una
Arteaga, Carmen
Jaime Garcia, Daniela
Hewins, Will
Jochems, Angela C.C.
Hamilton, Olivia K.L.
Manning, Cameron
Morgan, Alasdair G.
Locherty, Rachel
Cheng, Yajun
Liu, Xiaodi
Zhang, Junfang
Hamilton, Iona
Jardine, Charlotte
Brown, Rosalind
Sakka, Eleni
Kampaite, Agniete
Wiseman, Stewart
Valdés-Hernández, Maria C.
Chappell, Francesca M.
Doubal, Fergus N.
Marshall, Ian
Thrippleton, Michael J.
Wardlaw, Joanna M.
Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study
title Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study
title_full Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study
title_fullStr Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study
title_full_unstemmed Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study
title_short Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study
title_sort cerebrovascular reactivity in patients with small vessel disease: a cross-sectional study
topic Original Contributions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589433/
https://www.ncbi.nlm.nih.gov/pubmed/37814956
http://dx.doi.org/10.1161/STROKEAHA.123.042656
work_keys_str_mv AT sleightemilie cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT stringermichaels cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT clancyuna cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT arteagacarmen cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT jaimegarciadaniela cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT hewinswill cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT jochemsangelacc cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT hamiltonoliviakl cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT manningcameron cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT morganalasdairg cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT lochertyrachel cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT chengyajun cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT liuxiaodi cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT zhangjunfang cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT hamiltoniona cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT jardinecharlotte cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT brownrosalind cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT sakkaeleni cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT kampaiteagniete cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT wisemanstewart cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT valdeshernandezmariac cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT chappellfrancescam cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT doubalfergusn cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT marshallian cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT thrippletonmichaelj cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy
AT wardlawjoannam cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy